comscoreMale Breast Cancer

Male Breast Cancer

25 Research news
 
 
Article
Ibrance Approved to Treat Men With Advanced-Stage Hormone-Receptor-Positive Breast Cancer

The FDA has approved Ibrance to treat men diagnosed with advanced-stage hormone-receptor-positive, HER2-negative breast cancer.

 
Article
U.S. Black Men Have Higher Rates of All Types of Breast Cancer Compared to White Men

Black men have higher rates of all types of breast cancer compared to white men in the United States.

Jan 7, 2020 | Male Breast Cancer and Ethnicity
 
Article
Experimental Elacestrant Shows Promise for Pre-Treated Metastatic, Hormone Receptor-Positive, HER2-Negative Breast Cancer

Experimental elacestrant offered better progression-free survival than standard hormonal therapy for post-menopausal women and men diagnosed with metastatic, hormone receptor-positive, HER2-negative breast cancer that had grown during treatment with hormonal therapy and a CDK4/6 inhibitor.

 
Article
In Men, Characteristics of BRCA1-Linked Cancers Differ From Those of BRCA2-Linked Cancers

A study suggests that there are differences in the characteristics of cancers linked to a BRCA1 mutation compared to those of cancers linked to a BRCA2 mutation in men.

Jul 13, 2020 | Male Breast Cancer
 
Article
Risk of Second Cancer Higher in Men Diagnosed With Breast Cancer

Men who have been diagnosed with breast cancer have a higher risk of developing a second, new cancer.

 
Article
Men Treated With Tamoxifen for Breast Cancer Have Higher Risk of Blood Clots

Men diagnosed with hormone-receptor-positive breast cancer treated with tamoxifen had more than twice the risk of developing a blood clot compared to men with a similar diagnosis who were not treated with tamoxifen.

 
Article
Piqray Improves Overall Survival for Advanced-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer With PIK3CA Mutation

Postmenopausal women and men diagnosed with advanced-stage hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation lived about 8 months longer when treated with the combination of the targeted therapy Piqray and the hormonal therapy Faslodex compared to Faslodex alone.

 
Article
White and Black Men With Breast Cancer Receive Similar Treatment but Black Men Have Worse Outcomes

White and Black men diagnosed with early-stage breast cancer receive similar treatment, but Black men have worse outcomes.

May 12, 2015 | Male Breast Cancer and Ethnicity
 
Article
Men With Breast Cancer Have Lower Survival Rates Than Women

A study found that men have lower overall survival compared to women after a breast cancer diagnosis. The characteristics of the breast cancers and undertreatment of male breast cancer seem to account for much of the difference in survival.

Sep 23, 2019 | Male Breast Cancer
 
Article
Black Men Hit Harder by Breast Cancer

Similar to studies in women, Black men are more likely to have more aggressive breast cancer than white men.

Apr 6, 2007 | Male Breast Cancer and Ethnicity
 
Article
Many Men Stop Taking Tamoxifen

Many men diagnosed with breast cancer have problems while taking tamoxifen and about 20% of them stop taking it because of unacceptable side effects.

 
Article
Men Have Lower Breast Cancer Survival Rate Than Women

A large study has found that men diagnosed with early-stage breast cancer are more likely to die from the disease than women.

May 17, 2012 | Diagnosis and Male Breast Cancer
 
Article
Breast Cancer in Men Biologically Different Than Breast Cancer in Women

The characteristics of male breast cancer associated with outcomes are different than the characteristics of female breast cancer that are associated with outcomes.

Mar 22, 2016 | Male Breast Cancer
 
Article
Rates of Preventive Double Mastectomy in Men Nearly Doubles

A study has found that rates of contralateral preventive mastectomy in men nearly doubled between 2004 and 2011.

Sep 3, 2015 | Male Breast Cancer
 
Article
Treatment of Male Breast Cancer Has Evolved, Study Shows

While there have been no clinical trials specifically focused on male breast cancer in the United States, treatment of this disease has evolved over the years and researchers now know factors linked to better survival.

Oct 14, 2019 | Male Breast Cancer
 
Article
A New Standard of Care? Enhertu Improves Survival in People With Metastatic HER2-Low Breast Cancer

Compared with doctors’ choice of chemotherapy, Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) improved both progression-free survival and overall survival in people diagnosed with previously treated metastatic HER2-low breast cancer.

 
Article
Early-Stage Breast Cancer More Deadly in Men Than Women

Men have worse survival than women when diagnosed with early-stage breast cancer.

May 9, 2007 | Diagnosis and Male Breast Cancer
 
Article
FDA Says Men Should Be in Breast Cancer Studies

Men should be included in breast cancer clinical trials, according to draft guidance issued by the FDA.

Aug 29, 2019 | Male Breast Cancer
 
Article
Male Breast Cancer Is Different in Terms of Biology and Outcomes

While survival for men diagnosed with breast cancer has improved, it hasn't kept up with the improvements in survival for women with breast cancer.

Dec 17, 2014 | Male Breast Cancer
 
Article
Combination Hormonal Therapy Seems More Effective for Men With Hormone-Receptor-Positive Breast Cancer

The combination of either tamoxifen or an aromatase inhibitor plus a gonadotropin-releasing hormone analogue reduced levels of estradiol, a form of estrogen, more than tamoxifen alone in men diagnosed with hormone-receptor-positive breast cancer.

 
Article
Breast Cancer in Men Has Distinctive Biological Features

The expression of genes that control the number of estrogen receptors, the rate of cell division, and the ability of the cancer to invade healthy tissue was higher in breast cancers in men than in breast cancers in women.

Jun 6, 2018 | Male Breast Cancer
 
Article
ASCO Issues Guidelines on Managing Male Breast Cancer

Because not much research has been done on male breast cancer specifically, ASCO guidelines recommend managing it much the same way breast cancer is managed in women.

Mar 18, 2020 | Male Breast Cancer
 
Article
Including Risk of Common Genetic Variants May Lead to Better Estimates of Breast and Prostate Cancer Risk in Men With BRCA1/2 Mutations

Researchers combined the risk of common genetic variants associated with breast and prostate cancer to better estimate breast and prostate cancer risk in men with BRCA1/2 mutations.

Jul 12, 2017 | Male Breast Cancer
 
Article
Men With BRCA Mutations Have Much Higher Risk of Cancer

One of the largest studies of its kind has found that men with BRCA mutations developed 8 times as many cancers as would have been in expected in the general population.

May 25, 2017 | Male Breast Cancer
Showing 24 of 25